Home › Funds › Point72 Asset Management › PYXS
Point72 Asset Management position in PYXS
PYXIS ONCOLOGY INC · Health Care
Latest position (Q2 2026)37.09K sh
Reported value held$111.65K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 251.80K | $1.01M | New |
| Q4 2025 | 188.14K | $216.36K | New |
| Q1 2026 | 32.01K | $46.73K | Reduce |
| Q2 2026 | 37.09K | $111.65K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PYXS
- Vanguard Group 2.34M sh · $2.69M · Q4 2025
- BlackRock Inc 867.93K sh · $2.61M · Q2 2026
- Marshall Wace 830.54K sh · $2.50M · Q2 2026
- Renaissance Technologies 772.23K sh · $2.32M · Q2 2026
- Geode Capital Management 591.85K sh · $1.78M · Q2 2026
- Millennium Management 233.00K sh · $701.34K · Q2 2026
- UBS Group AG 155.22K sh · $467.20K · Q2 2026
- BNY Mellon 134.00K sh · $403.33K · Q2 2026
- Northern Trust Corp 123.96K sh · $373.12K · Q2 2026
- Two Sigma Investments 83.96K sh · $252.72K · Q2 2026
- Bank of America Corp 80.46K sh · $242.20K · Q2 2026
- Citadel Advisors 62.02K sh · $186.67K · Q2 2026